The only DLBCL model investigated which neither responded to AZD8186 monotreatment nor to the combination with AZD2014, was OCI-Ly3, which harbors the CARD11L244P gain-of-function mutation [49]. The gene discussed is CD8B; the disease is diffuse large B-cell lymphoma.